Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease
Pituitary adenomas constitute up to 20% of primary brain tumors, yet somatic mutations are only found in 15% of pituitary adenomas. Epigenomic dysregulation has been proposed as a tumorigenic mechanism in pituitary adenomas causing Cushing’s disease (CD). We created paired datasets of human CD adenomas and en-route margin adult human pituitary glands, and assayed their chromatin accessibility, DNA methylation, transcriptomic, proteomic, and phospho-proteomic landscapes. In CD adenomas, we found epigenetic reactivation of a neurodevelopmental phosphoprotein program typically lost in the postnatal pituitary gland. CD cells overexpressed PPP1R17 , an endogenous inhibitor of the protein phosphatase PP2A. Mechanistically, PPP1R17 overexpression in normal murine pituitary cells recapitulated the adenoma phenotype, and the resulting hyperproliferation was reversed in a PP2A-dependent manner by fingolimod, an FDA-approved small molecule, both in vitro and in vivo. Our findings highlight kinase-phosphatase imbalance as a targetable mechanism in CD.
Authors
- Christina Tatsi (ORCID: https://orcid.org/0000-0002-2882-4584)
- Nasir Malik
- Debjani Mandal (ORCID: https://orcid.org/0000-0002-0230-6981)
- Joseph P. Steiner (ORCID: https://orcid.org/0000-0003-0284-631X)
- Susan Wray (ORCID: https://orcid.org/0000-0001-7670-3915)
- Clarisse Quignon (ORCID: https://orcid.org/0009-0009-2681-775X)
- Lynnette K. Nieman (ORCID: https://orcid.org/0000-0003-0534-8025)
- Zied Abdullaev (ORCID: https://orcid.org/0000-0001-6345-2088)
- Sheelu Varghese
- Dustin Mullaney (ORCID: https://orcid.org/0000-0003-1197-6976)
- David T. Asuzu (ORCID: https://orcid.org/0000-0001-7011-479X)
- Kenneth Aldape (ORCID: https://orcid.org/0000-0001-5119-7550)
- Diana Nwokoye
- Dragan Maric (ORCID: https://orcid.org/0000-0003-2912-7921)
- Prashant Chittiboina (ORCID: https://orcid.org/0000-0001-9349-4756)
- Nikhil Ramavenkat
- Yan Li (ORCID: https://orcid.org/0000-0003-3820-5960)
- Kory R. Johnson (ORCID: https://orcid.org/0000-0002-6693-3378)
- Abdel G. Elkahloun (ORCID: https://orcid.org/0000-0001-7085-0762)
- Dhruval Bhatt
- Daniela Tortoza Lopez
Institutions
- National Institutes of Health (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- National Institute of Neurological Disorders and Stroke (US)
- National Cancer Institute (MY)
- National Cancer Institute (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of Virginia (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-09-29
- DOI
- https://doi.org/10.1073/pnas.2528513123
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00